The IRF family of transcription factors: Inception, impact and implications in oncogenesis

Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins

Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · see citing works

Papillomaviruses and cancer: from basic studies to clinical application

Hausen, H. Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc798 · Cited by 4,031 · see citing works

IRF-7 is the master regulator of type-I interferon-dependent immune responses

Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,229 · see citing works

IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors

Honda, K., & Taniguchi, T. (2006) · Nature reviews. Immunology · doi:10.1038/nri1900 · Cited by 1,676 · see citing works

IRF Family of Transcription Factors as Regulators of Host Defense

Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658 · see citing works

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)

Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14862 · Cited by 1,457 · see citing works

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Benmaad, I., Caldéraro, J., Bioulac‐Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,451 · see citing works

Inflammation meets cancer, with NF-κB as the matchmaker

Ben‐Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,378 · see citing works

Distinct and Essential Roles of Transcription Factors IRF-3 and IRF-7 in Response to Viruses for IFN-α/β Gene Induction

Sato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., Katsuki, M., Noguchi, S., Tanaka, N., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00053-4 · Cited by 1,342 · see citing works

The IRF Family Transcription Factors in Immunity and Oncogenesis

Tamura, T., Yanai, H., Savitsky, D., & Taniguchi, T. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090400 · Cited by 1,259 · see citing works

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

Li, K., Foy, E. M., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408824102 · Cited by 1,092 · see citing works

Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements

Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T., & Taniguchi, T. (1988) · Cell · doi:10.1016/s0092-8674(88)91307-4 · Cited by 977 · see citing works

Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes

Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90107-4 · Cited by 957 · see citing works

Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV

Moore, P. S., Boshoff, C., Weiss, R. A., & Chang, Y. (1996) · Science · doi:10.1126/science.274.5293.1739 · Cited by 900 · see citing works

Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes

Kondo, S., Schutte, B. C., Richardson, R. J., Bjork, B. C., Knight, A. S., Watanabe, Y., Howard, E., de Lima, R. L. L. F., Daack‐Hirsch, S., Sander, A., et al. (2002) · Nature Genetics · doi:10.1038/ng985 · Cited by 893 · see citing works

Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence

Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T., Honda, K., et al. (2003) · Nature · doi:10.1038/nature01850 · Cited by 847 · see citing works

IRF4 addiction in multiple myeloma

Shaffer, A. L., Emre, N. C. T., Lamy, L., Ngo, V. N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H., et al. (2008) · Nature · doi:10.1038/nature07064 · Cited by 730 · see citing works

Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene

Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644 · see citing works

Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activityPreprint

Ronco, L. V., Karpova, A. Y., Vidal, M., & Howley, P. M. (1998) · Genes & Development · doi:10.1101/gad.12.13.2061 · Cited by 631 · see citing works

Interferon regulatory factors: the next generation

Mamane, Y., Heylbroeck, C., Génin, P., Algarté-Génin, M., Servant, M. J., Page, C. L., DeLuca, C., Kwon, H., Lin, R., & Hiscott, J. B. (1999) · Gene · doi:10.1016/s0378-1119(99)00262-0 · Cited by 570 · see citing works

Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma

Yang, Y., Shaffer, A. L., Emre, N. C. T., Ceribelli, M., Zhang, M., Wright, G. W., Xiao, W., Powell, J. I., Platig, J., Kohlhammer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.024 · Cited by 524 · see citing works

Antiviral innate immunity pathways

Seth, R. B., Sun, L., & Chen, Z. J. (2006) · Cell Research · doi:10.1038/sj.cr.7310019 · Cited by 492 · see citing works

Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1

Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491 · see citing works

Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape

Bidwell, B. N., Slaney, C. Y., Withana, N. P., Forster, S., Cao, Y., Loi, S., Andrews, D., Mikeska, T., Mangan, N. E., Samarajiwa, S. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2830 · Cited by 487 · see citing works

The growing family of interferon regulatory factors

Nguyen, H., Hiscott, J., & Pitha, P. M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00019-1 · Cited by 480 · see citing works

Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro.Preprint

Levy, D. E., Kessler, D. S., Pine, R. I., & Darnell, J. E., Jr. (1989) · Genes & Development · doi:10.1101/gad.3.9.1362 · Cited by 468 · see citing works

Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.

Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447 · see citing works

Anti-Oncogenic and Oncogenic Potentials of Interferon Regulatory Factors-1 and -2

Harada, H., Kitagawa, M., Tanaka, N., Yamamoto, H., Harada, K., Ishihara, M., & Taniguchi, T. (1993) · Science · doi:10.1126/science.8438157 · Cited by 436 · see citing works

An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes

Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., & Taniguchi, T. (1995) · Nature · doi:10.1038/376596a0 · Cited by 431 · see citing works

Deletion of IRF-1 , Mapping to Chromosome 5q31.1, in Human Leukemia and Preleukemic Myelodysplasia

Willman, C. L., Sever, C. E., Pallavicini, M. G., Harada, H., Tanaka, N., Slovak, M. L., Yamamoto, H., Harada, K., Meeker, T. C., List, A. F., et al. (1993) · Science · doi:10.1126/science.8438156 · Cited by 380 · see citing works

Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKε‐mediated IRF activation

Schröder, M., Baran, M., & Bowie, A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.143 · Cited by 374 · see citing works

An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes

石原, 正. (1997) · Cited by 366 · see citing works

The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4

Hsu, L.-C., Park, J. M., Zhang, K., Luo, J., Maeda, S., Kaufman, R. J., Eckmann, L., Guiney, D. G., & Karin, M. (2004) · Nature · doi:10.1038/nature02405 · Cited by 357 · see citing works

Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6)

Ingraham, C. R., Kinoshita, A., Kondo, S., Yang, B., Sajan, S. A., Trout, K. J., Malik, M., Dunnwald, M., Goudy, S. L., Lovett, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1903 · Cited by 356 · see citing works

An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes.

Driggers, P. H., Ennist, D. L., Gleason, S. L., Mak, W. H., Marks, M. S., Levi, B. Z., Flanagan, J. R., Appella, E., & Ozato, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3743 · Cited by 356 · see citing works

Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma

Iida, S., Rao, P. H., Butler, M. P., Corradini, P., Boccadoro, M., Klein, B., CHAGANTI, R. S. K., & Dalla‐Favera, R. (1997) · Nature Genetics · doi:10.1038/ng1097-226 · Cited by 335 · see citing works

Inactivation of Interferon Regulatory Factor-1 Tumor Suppressor Protein by HPV E7 Oncoprotein

Park, J. S., Kim, E., Kwon, H.-J., Hwang, E.-S., Namkoong, S.-E., & Um, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6764 · Cited by 333 · see citing works

Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch

Richardson, R. J., Dixon, J., Malhotra, S., Hardman, M. J., Knowles, L., Boot-Handford, R., Shore, P., Whitmarsh, A. J., & Dixon, M. J. (2006) · Nature Genetics · doi:10.1038/ng1894 · Cited by 325 · see citing works

Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage

Tanaka, N., Ishihara, M., Lamphier, M. S., Nozawa, H., Matsuyama, T., Mak, T. W., Aizawa, S., Tokino, T., Oren, M., & Taniguchi, T. (1996) · Nature · doi:10.1038/382816a0 · Cited by 324 · see citing works

Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator.

Kessler, D. S., Veals, S. A., Fu, X. Y., & Levy, D. E. (1990) · Genes & Development · doi:10.1101/gad.4.10.1753 · Cited by 312 · see citing works

Regulation of immunity and oncogenesis by the IRF transcription factor family

Savitsky, D., Tamura, T., Yanai, H., & Taniguchi, T. (2010) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-009-0804-6 · Cited by 298 · see citing works

The IRF family, revisited

Paun, A., & Pitha, P. M. (2007) · Biochimie · doi:10.1016/j.biochi.2007.01.014 · Cited by 277 · see citing works

The KSHV Immediate-Early Transcription Factor RTA Encodes Ubiquitin E3 Ligase Activity that Targets IRF7 for Proteosome-Mediated Degradation

Yu, Y., Wang, S. E., & Hayward, G. S. (2005) · Immunity · doi:10.1016/j.immuni.2004.11.011 · Cited by 274 · see citing works

Influence of sun exposures during childhood and during adulthood on melanoma risk

Autier, P., & Doré, J. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980812)77:4 · Cited by 235 · see citing works

Poxvirus Protein N1L Targets the I-κB Kinase Complex, Inhibits Signaling to NF-κB by the Tumor Necrosis Factor Superfamily of Receptors, and Inhibits NF-κB and IRF3 Signaling by Toll-like Receptors

DiPerna, G., Stack, J., Bowie, A., Boyd, A., Kotwal, G. J., ZHANG, Z., Arvikar, S. L., Latz, E., Fitzgerald, K. A., & Marshall, W. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400567200 · Cited by 233 · see citing works

Molecular cloning ofLSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE)

Matsuyama, T., Grossman, A., Mittrücker, H.-W., Siderovski, D. P., Kiefer, F., Kawakami, T., Richardson, C. D., Taniguchi, T., Yoshinaga, S. K., & Mak, T. W. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.12.2127 · Cited by 232 · see citing works

Crystal structure of an IRF‐DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences

Fujii, Y., Shimizu, T., Kusumoto, M., Kyogoku, Y., Taniguchi, T., & Hakoshima, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5028 · Cited by 223 · see citing works

Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression

Yanai, H., Chen, H.-M., Inuzuka, T., Kondo, S., Mak, T. W., Takaoka, A., Honda, K., & Taniguchi, T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611559104 · Cited by 216 · see citing works

Functional Analysis of Human Herpesvirus 8-Encoded Viral Interferon Regulatory Factor 1 and Its Association with Cellular Interferon Regulatory Factors and p300

Burýšek, L., Yeow, W.-S., Lubyová, B., Kellum, M. J., Schafer, S. L., Huang, Y. Q., & Pitha, P. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7334-7342.1999 · Cited by 212 · see citing works

Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas

Feldman, A. L., Law, M., Remstein, E. D., Macon, W. R., Erickson, L. A., Grogg, K. L., Pj, K., & Doǧan, A. (2008) · Leukemia · doi:10.1038/leu.2008.320 · Cited by 210 · see citing works

Rotavirus NSP1 Inhibits Expression of Type I Interferon by Antagonizing the Function of Interferon Regulatory Factors IRF3, IRF5, and IRF7

Barro, M., & Patton, J. T. (2007) · Journal of Virology · doi:10.1128/jvi.02498-06 · Cited by 205 · see citing works

Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias

Schmidt, M., Nagel, S., Proba, J., Thiede, C., Ritter, M., Waring, J. F., Rosenbauer, F., Huhn, D., Wittig, B., Horak, I., et al. (1998) · Blood · doi:10.1182/blood.v91.1.22 · Cited by 199 · see citing works

A Novel Interferon Regulatory Factor Family Transcription Factor, ICSAT/Pip/LSIRF, That Negatively Regulates the Activity of Interferon-Regulated Genes

Yamagata, T., Nishida, J., Tanaka, T., Sakai, R., Mitani, K., Yoshida, M., Taniguchi, T., Yazaki, Y., & Hirai, H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1283 · Cited by 196 · see citing works

TLR pathways and IFN‐regulatory factors: To each its own

Colonna, M. (2007) · European Journal of Immunology · doi:10.1002/eji.200637009 · Cited by 193 · see citing works

The Interferon Regulatory Factor Family in Host Defense: Mechanism of Action

Ozato, K., Tailor, P. B., & Kubota, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700003200 · Cited by 191 · see citing works

Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2

Vaughan, P. S., Aziz, F., van Wijnen, A. J., Wu, S., Harada, H., Taniguchi, T., Soprano, K. J., Stein, J. L., & Stein, G. S. (1995) · Nature · doi:10.1038/377362a0 · Cited by 189 · see citing works

IRF4: Immunity. Malignancy! Therapy?

Shaffer, A. L., Emre, N. C. T., Romesser, P. B., & Staudt, L. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1845 · Cited by 189 · see citing works

The Feedback Phase of Type I Interferon Induction in Dendritic Cells Requires Interferon Regulatory Factor 8

Tailor, P. B., Tamura, T., Kong, H. J., Kubota, T., Kubota, M., Borghi, P., Gabriele, L., & Ozato, K. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.009 · Cited by 179 · see citing works

Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity

Kondo, T., Minamino, N., Nagamura‐Inoue, T., Matsumoto, M., Taniguchi, T., & Tanaka, N. (1997) · Oncogene · doi:10.1038/sj.onc.1201286 · Cited by 177 · see citing works

Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death.

Barnes, B. J., Kellum, M. J., Pinder, K. E., Frisancho, J. A., & Pitha, P. M. (2003) · PubMed · Cited by 175 · see citing works

Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53

Mori, T., Anazawa, Y., Iiizumi, M., Fukuda, S., Nakamura, Y., & Arakawa, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205459 · Cited by 164 · see citing works

The IRF-3 Transcription Factor Mediates Sendai Virus-Induced Apoptosis

Heylbroeck, C., Balachandran, S., Servant, M. J., DeLuca, C., Barber, G. N., Lin, R., & Hiscott, J. B. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3781-3792.2000 · Cited by 162 · see citing works

Dynamic Evolution of Immune System Regulators: The History of the Interferon Regulatory Factor Family

Nehyba, J., Hrdličková, R., & Bose, H. R. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp167 · Cited by 153 · see citing works

Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes.

Weisz, A., Marx, P., Sharf, R., Appella, E., Driggers, P. H., Ozato, K., & Levi, B. Z. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74081-2 · Cited by 152 · see citing works

Interferon regulatory factor family of transcription factors and regulation of oncogenesis

Takaoka, A., Tamura, T., & Taniguchi, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00720.x · Cited by 150 · see citing works

Protein-Protein and DNA-Protein Interactions Affect the Activity of Lymphoid-Specific IFN Regulatory Factors

Meraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6468 · Cited by 147 · see citing works

Expression of Interferon Consensus Sequence Binding Protein (ICSBP) Is Downregulated in Bcr-Abl-Induced Murine Chronic Myelogenous Leukemia-Like Disease, and Forced Coexpression of ICSBP Inhibits Bcr-Abl-Induced Myeloproliferative Disorder

Hao, S. X., & Ren, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1149-1161.2000 · Cited by 143 · see citing works

Inhibition of Interferon Regulatory Factor 7 (IRF7)-Mediated Interferon Signal Transduction by the Kaposi's Sarcoma-Associated Herpesvirus Viral IRF Homolog vIRF3

Joo, C. H., Shin, Y. C., Gack, M. U., Wu, L., Levy, D. E., & Jung, J. U. (2007) · Journal of Virology · doi:10.1128/jvi.00235-07 · Cited by 142 · see citing works

Inhibition of p300 Histone Acetyltransferase by Viral Interferon Regulatory Factor

Li, M., Damania, B., Alvarez, X., Ogryzko, V., Ozato, K., & Jung, J. U. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8254-8263.2000 · Cited by 142 · see citing works

A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias

Moretti, F., Marinari, B., Iacono, N. L., Botti, E., Giunta, A., Spallone, G., Garaffo, G., Vernersson-Lindahl, E., Merlo, G. R., Mills, A. A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40267 · Cited by 140 · see citing works

IRF-1 Is an Essential Mediator in IFN-γ-Induced Cell Cycle Arrest and Apoptosis of Primary Cultured Hepatocytes

Kano, A., Haruyama, T., Akaike, T., & Watanabe, Y. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0276 · Cited by 135 · see citing works

Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).

Burýšek, L., Yeow, W.-S., & Pitha, P. M. (1999) · PubMed · Cited by 127 · see citing works

Interferon regulatory factor-3 is an in vivo target of DNA-PK

Karpova, A. Y., Trost, M., Murray, J. M., Cantley, L. C., & Howley, P. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052713899 · Cited by 122 · see citing works

Signaling through IFN Regulatory Factor-5 Sensitizes p53-Deficient Tumors to DNA Damage–Induced Apoptosis and Cell Death

Hu, G., Mancl, M. E., & Barnes, B. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0583 · Cited by 122 · see citing works

Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53Preprint

Nozawa, H., Oda, E., Nakao, K., Ishihara, M., Ueda, S., Yokochi, T., Ogasawara, K., Nakatsuru, Y., SHIMIZU, S., Ohira, Y., et al. (1999) · Genes & Development · doi:10.1101/gad.13.10.1240 · Cited by 120 · see citing works

IRF6 is a mediator of Notch pro‐differentiation and tumour suppressive function in keratinocytes

Restivo, G., Nguyen, B.-C., Dziunycz, P., Ristorcelli, E., Ryan, R. J. H., Yalcin-Ozuysal, Ö., Piazza, M., Radtke, F., Dixon, M. J., Hofbauer, G. F. L., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.325 · Cited by 118 · see citing works

Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation.

Harada, H., Kondo, T., Ogawa, S., Tamura, T., Kitagawa, M., Tanaka, N., Lamphier, M. S., Hirai, H., & Taniguchi, T. (1994) · PubMed · Cited by 114 · see citing works

TRAF6 and the Three C-Terminal Lysine Sites on IRF7 Are Required for Its Ubiquitination-Mediated Activation by the Tumor Necrosis Factor Receptor Family Member Latent Membrane Protein 1

Ning, S., Campos, A. R., Darnay, B. G., Bentz, G. L., & Pagano, J. S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00785-08 · Cited by 114 · see citing works

Interferon Regulatory Factor 3 Is a Cellular Partner of Rotavirus NSP1

Graff, J. W., Mitzel, D., Weisend, C. M., Flenniken, M. L., & Hardy, M. E. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9545-9550.2002 · Cited by 114 · see citing works

Interferon Regulatory Factor 6 Promotes Cell Cycle Arrest and Is Regulated by the Proteasome in a Cell Cycle-Dependent Manner

Bailey, C. M., Abbott, D. E., Margaryan, N. V., Khalkhali‐Ellis, Z., & Hendrix, M. J. C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01866-07 · Cited by 113 · see citing works

Epstein‐Barr Virus: The First Human Tumor Virus and its Role in Cancer

Pagano, J. S. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.t01-1-99220.x · Cited by 111 · see citing works

Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach.

Tamura, G., Ogasawara, S., Nishizuka, S., Sakata, K., Maesawa, C., Suzuki, Y. A., Terashima, M., Saito, K., & Satodate, R. (1996) · PubMed · Cited by 105 · see citing works

Activation of Interferon Regulatory Factor 3 in Response to DNA-damaging Agents

Kim, T. I., Kim, T. Y., Song, Y., Min, I. M., Yim, J., & Kim, T. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30686 · Cited by 102 · see citing works

Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2

Burchert, A. (2003) · Blood · doi:10.1182/blood-2003-08-2970 · Cited by 102 · see citing works

Lysyl Oxidase Inhibits Ras-Mediated Transformation by Preventing Activation of NF-κB

Jeay, S., Pianetti, S., Kagan, H. M., & Sonenshein, G. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2251-2263.2003 · Cited by 97 · see citing works

Repression of IFN Regulatory Factor 8 by DNA Methylation Is a Molecular Determinant of Apoptotic Resistance and Metastatic Phenotype in Metastatic Tumor Cells

Yang, D., Thangaraju, M., Greeneltch, K. M., Browning, D. D., Schoenlein, P. V., Tamura, T., Ozato, K., Ganapathy, V., Abrams, S. I., & Liu, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4068 · Cited by 94 · see citing works

The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain.

Yamamoto, H., Lamphier, M. S., Fujita, T., Taniguchi, T., & Harada, H. (1994) · PubMed · Cited by 91 · see citing works

Common deleted region on the long arm of chromosome 5 in esophageal carcinoma

Ogasawara, S., Tamura, G., Maesawa, C., Suzuki, Y. A., Ishida, K., Satoh, N., Uesugi, N., Saito, K., & Satodate, R. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536888 · Cited by 89 · see citing works

Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway

Pamment, J., Ramsay, E., Kelleher, M., Dornan, D., & Ball, K. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205981 · Cited by 88 · see citing works

Cell Cycle Regulation of Histone H4 Gene Transcription Requires the Oncogenic Factor IRF-2

Vaughan, P. S., van der Meijden, C. M. J., Aziz, F., Harada, H., Taniguchi, T., van Wijnen, A. J., Stein, J. L., & Stein, G. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.194 · Cited by 83 · see citing works

Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression.

Tan, R. S., Taniguchi, T., & Harada, H. (1996) · PubMed · Cited by 83 · see citing works

Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1

Tanaka, N., Ishihara, M., & Taniguchi, T. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90318-2 · Cited by 80 · see citing works

Epigenetic disruption of interferon-γ response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas

Lee, K. Y., Geng, H., Ng, K. M., Yu, J. Q., van Hasselt, A., Cao, Y., Zeng, Y.-X., Wong, A., Wang, X., Ying, J., et al. (2008) · Oncogene · doi:10.1038/onc.2008.147 · Cited by 78 · see citing works

Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α

Schmidt, M., Hochhaus, A., Nitsche, A., Hehlmann, R., & Neubauer, A. (2001) · Blood · doi:10.1182/blood.v97.11.3648 · Cited by 77 · see citing works

Interferon regulatory factor‐1 mediates interferon‐γ‐induced apoptosis in ovarian carcinoma cells

Kim, E., Lee, J.-M., Namkoong, S., Um, S., & Park, J. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10142 · Cited by 75 · see citing works

The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5

Wies, E., Hahn, A. S., Schmidt, K. M., Viebahn, C., Rohland, N., Lux, A., Schellhorn, T., Holzer, A., Jung, J. U., & Neipel, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809252200 · Cited by 73 · see citing works

IRF8 Regulates Acid Ceramidase Expression to Mediate Apoptosis and Suppresses Myelogeneous Leukemia

Hu, X., Yang, D., Zimmerman, M. A., Liu, F., Yang, J., Kannan, S., Burchert, A., Szulc, Z. M., Bielawska, A. E., Ozato, K., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2493 · Cited by 72 · see citing works

A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis

Couzinet, A., Tamura, K., Chen, H., Nishimura, K., Wang, Z., Morishita, Y., Takeda, K., Yagita∥, H., Yanai, H., Taniguchi, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712295105 · Cited by 71 · see citing works

Interferon Regulatory Factor Expression in Human Breast Cancer

Doherty, G. M., Boucher, L. D., Sorenson, K., & Lowney, J. K. (2001) · Annals of Surgery · doi:10.1097/00000658-200105000-00005 · Cited by 71 · see citing works

Identification of TRAIL as an Interferon Regulatory Factor 3 Transcriptional Target

Kirshner, J. R., Karpova, A. Y., Kops, M., & Howley, P. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.9320-9324.2005 · Cited by 70 · see citing works

Apoptosis is promoted by the dsRNA‐activated factor (DRAF1) during viral infection independent of the action of interferon or p53

WEAVER, B. K., ANDO, O., Kumar, K. P., & Reich, N. C. (2001) · The FASEB Journal · doi:10.1096/fj.00-0222com · Cited by 68 · see citing works

Epigenetic Silencing of IRF7 and/or IRF5 in Lung Cancer Cells Leads to Increased Sensitivity to Oncolytic Viruses

Li, Q., & Tainsky, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028683 · Cited by 68 · see citing works

Interferon Regulatory Factor 7 Is Associated with Epstein-Barr Virus-Transformed Central Nervous System Lymphoma and Has Oncogenic Properties

Zhang, L., Zhang, J., Lambert, Q. T., Der, C. J., Valle, L. D., Judith Miklossy, A., Khalili, K., Zhou, Y., & Pagano, J. S. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12987-12995.2004 · Cited by 66 · see citing works

Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis

Bi, X., Hameed, M., Mirani, N. M., Pimenta, E. M., Anari, J. B., & Barnes, B. J. (2011) · Breast Cancer Research · doi:10.1186/bcr3053 · Cited by 66 · see citing works

Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis

Park, J., Kim, K., Lee, E., Seo, Y.-J., Lim, S., Park, K., Rho, S. B., Lee, S., & Lee, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609852104 · Cited by 63 · see citing works

ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells

Tamura, T., Kong, H. J., Tunyaplin, C., Tsujimura, H., Calame, K. L., & Ozato, K. (2003) · Blood · doi:10.1182/blood-2003-01-0291 · Cited by 61 · see citing works

A ChIP–chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response

Frontini, M., Vijayakumar, M., Garvin, A. J., & Clarke, N. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1051 · Cited by 60 · see citing works

Role of IRF‐1 and caspase‐7 in IFN‐γ enhancement of Fas‐mediated apoptosis in ACHN renal cell carcinoma cells

Tomita, Y., Bilim, V. N., Hara, N., Kasahara, T., & Takahashi, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.10956 · Cited by 59 · see citing works

Interferon Regulatory Factor-2 Regulates Cell Growth through Its Acetylation

Masumi, A., Yamakawa, Y., Fukazawa, H., Ozato, K., & Komuro, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213037200 · Cited by 55 · see citing works

The Interferon Consensus Sequence-binding Protein (ICSBP/IRF8) Represses PTPN13 Gene Transcription in Differentiating Myeloid Cells

Huang, W., Zhu, C., Wang, H., Horvath, E., & Eklund, E. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706710200 · Cited by 54 · see citing works

IRF4 Is a Suppressor of c-Myc Induced B Cell Leukemia

Pathak, S., Ma, S., Trinh, L., Eudy, J. D., Wagner, K., Joshi, S. S., & Lu, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022628 · Cited by 54 · see citing works

Kaposi Sarcoma Herpesvirus-Encoded Interferon Regulator Factors

Offermann, M. K. (2006) · Springer eBooks · doi:10.1007/978-3-540-34344-8_7 · Cited by 51 · see citing works

Expression of Interferon Regulatory Factor 4 in Chronic Myeloid Leukemia: Correlation With Response to Interferon Alfa Therapy

Schmidt, M., Hochhaus, A., König-Merediz, S. A., Brendel, C. A., Proba, J., Hoppe, G. J., Wittig, B., Ehninger, G., Hehlmann, R., & Neubauer, A. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3331 · Cited by 51 · see citing works

Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.

Nguyen, H. T. T., Mustafa, A., Hiscott, J. B., & Lin, R. (1995) · PubMed · Cited by 51 · see citing works

IRF7 activation by Epstein–Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3

Song, Y., Izumi, K. M., Shinners, N. P., Gewurz, B. E., & Kieff, E. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809933105 · Cited by 50 · see citing works

Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia

Deng, M., & Daley, G. Q. (2001) · Blood · doi:10.1182/blood.v97.11.3491 · Cited by 50 · see citing works

In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors.

Duguay, D., Mercier, F., Stagg, J., Martineau, D., Bramson, J. L., Servant, M. J., Lin, R., Galipeau, J., & Hiscott, J. B. (2002) · PubMed · Cited by 49 · see citing works

Coordinate Regulation of IFN Consensus Sequence-Binding Protein and Caspase-1 in the Sensitization of Human Colon Carcinoma Cells to Fas-Mediated Apoptosis by IFN-γ

Liu, K., & Abrams, S. I. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6329 · Cited by 46 · see citing works

IRF6 in development and disease: A mediator of quiescence and differentiation

Bailey, C. M., & Hendrix, M. J. C. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6221 · Cited by 46 · see citing works

Interferon Regulatory Factor-8 Is Indispensable for the Expression of Promyelocytic Leukemia and the Formation of Nuclear Bodies in Myeloid Cells

Dror, N., Rave-Harel, N., Burchert, A., Azriel, A., Tamura, T., Tailor, P. B., Neubauer, A., Ozato, K., & Levi, B.-Z. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607825200 · Cited by 44 · see citing works

Oncogenic Potential of a Dominant Negative Mutant of Interferon Regulatory Factor 3

Kim, T. Y., Lee, K.-H., Chang, S., Chung, C., Lee, H.-W., Kim, T. K., & Kim, T. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205792200 · Cited by 42 · see citing works

Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer

Cavalli, L. R., Riggins, R. B., Wang, A., Clarke, R. C., & Haddad, B. R. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0509-8 · Cited by 41 · see citing works

Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region

Ortmann, C. A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki1001 · Cited by 40 · see citing works

The interferon-inducible murine p48 (ISGF3γ) gene is regulated by protooncogene c- myc

Weihua, X., Lindner, D. J., & Kalvakolanu, D. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7227 · Cited by 39 · see citing works

Low expression of interferon regulatory factor‐1 and identification of novel exons skipping in patients with chronic myeloid leukaemia

Tzoanopoulos, D., Speletas, M. G., Arvanitidis, K. I., Veiopoulou, C., Kyriaki, S., Thyphronitis, G., Sideras, P., Kartalis, G., & Ritis, K. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03829.x · Cited by 38 · see citing works

Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2

Pettersson, S., Kelleher, M., Pion, E., Wallace, M., & Ball, K. L. (2008) · Biochemical Journal · doi:10.1042/bj20082087 · Cited by 37 · see citing works

Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma

Heintel, D., Zojer, N., Schreder, M., Strasser‐Weippl, K., Kainz, B., Vesely, M., Gisslinger, H., Drach, J. W., Gaiger, A., Jaeger, U., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404895 · Cited by 36 · see citing works

Repression of IRF-4 target genes in human T cell leukemia virus-1 infection

Mamane, Y., Grandvaux, N., Hernandez, E., Sharma, S., Innocente, S. A., Lee, J. M., Azimi, N., Lin, R., & Hiscott, J. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205843 · Cited by 35 · see citing works

N-Ras –Induced Growth Suppression of Myeloid Cells Is Mediated by IRF-1

Passioura, T., Dolnikov, A., Shen, S., & Symonds, G. P. (2005) · Cancer Research · doi:10.1158/0008-5472.797.65.3 · Cited by 33 · see citing works

IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cells

Cui, L., Deng, Y., Rong, Y., Lou, W., Mao, Z., Feng, Y., Xie, D., & Jin, D. (2011) · Tumor Biology · doi:10.1007/s13277-011-0273-3 · Cited by 32 · see citing works

A Multiprotein Binding Interface in an Intrinsically Disordered Region of the Tumor Suppressor Protein Interferon Regulatory Factor-1

Narayan, V., Halada, P., Hernychová, L., Chong, Y., Žáková, J., Hupp, T. R., Vojtěšek, B., & Ball, K. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204602 · Cited by 28 · see citing works

Functional Analysis of a Dominant Negative Mutation of Interferon Regulatory Factor 5

Yang, L., Zhao, T., Shi, X., Nakhaei, P., Wang, Y., Sun, Q., Hiscott, J. B., & Lin, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005500 · Cited by 27 · see citing works

Bilateral multiple renal oncocytomas and cysts associated with a constitutional translocation (8;9)(q24.1;q34.3) and a rare constitutional VHL missense substitution

Teh, B. T., Blennow, E., Giraud, S., Sahlén, S., Hii, S.-I., Brookwell, R., Brauch, H. B., Nordenskjöld, M., Larsson, C., & Nicol, D. L. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199803)21:3 · Cited by 25 · see citing works

ICSAT Overexpression Is Not Sufficient to Cause Adult T-Cell Leukemia or Multiple Myeloma

Saito, T., Yamagata, T., Takahashi, T., Honda, H., & Hirai, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0911 · Cited by 17 · see citing works

GAAP‐1: a transcriptional activator of p53 and IRF‐1 possesses pro‐apoptotic activity

Lallemand, C., Palmieri, M., Blanchard, B., Méritet, J., & Tovey, M. G. (2002) · EMBO Reports · doi:10.1093/embo-reports/kvf032 · Cited by 17 · see citing works

A retroviral library genetic screen identifies IRF-2 as an inhibitor of N-ras-induced growth suppression in leukemic cells

Passioura, T., Shen, S., Symonds, G. P., & Dolnikov, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208877 · Cited by 15 · see citing works

Aberrant expression of interferon regulatory factor 3 in human lung cancer

Tokunaga, T., Naruke, Y., Shigematsu, S., Kohno, T., Yasui, K., Ma, Y., Chua, K. J., Katayama, I., Nakamura, T., Hishikawa, Y., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.085 · Cited by 15 · see citing works

Analysis of Schistosoma mansoni genes shared with Deuterostomia and with possible roles in host interactions

Venâncio, T. M., Demarco, R. C., Almeida, G. T., Oliveira, K. C., Setúbal, J. C., & Verjovski‐Almeida, S. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-407 · Cited by 13 · see citing works

Repression of DNA Repair Mechanisms in IRF-4-Expressing and HTLV-I-Infected T Lymphocytes

Mamane, Y., Loignon, M., Palmer, J., Hernandez, E., Césaire, R., Alaoui‐Jamali, M. A., & Hiscott, J. B. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.43 · Cited by 10 · see citing works

Genome-wide cDNA microarray screening of genes related to survival in patients after curative resection of non-small cell lung cancer

Oshita, F., Sekiyama, A., Ito, H., Kameda, Y., & Miyagi, Y. (2006) · Oncology Reports · doi:10.3892/or.16.4.817 · Cited by 10 · see citing works

The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor FamilyPreprint

Negishi, H., Taniguchi, T., & Yanai, H. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028423 · Cited by 447 · see citing works

Regulating IRFs in IFN Driven Disease

Jefferies, C. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00325 · Cited by 364 · see citing works

The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2

Chistiakov, D. A., Myasoedova, V. A., Revin, V. V., Orekhov, A. N., & Bobryshev, Y. V. (2018) · Immunobiology · doi:10.1016/j.imbio.2017.10.005 · Cited by 311 · see citing works

Predicting RNA-seq coverage from DNA sequence as a unifying model of gene regulation

Linder, J., Srivastava, D., Yuan, H., Agarwal, V., & Kelley, D. R. (2025) · Nature Genetics · doi:10.1038/s41588-024-02053-6 · Cited by 265 · see citing works

The IRF Family Transcription Factors at the Interface of Innate and Adaptive Immune ResponsesPreprint

Ikushima, H., Negishi, H., & Taniguchi, T. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020321 · Cited by 269 · see citing works

Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease

Zhao, G., Jiang, D.-S., & Li, H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.030 · Cited by 212 · see citing works

Impact of the gut microbiome on the genome and epigenome of colon epithelial cells: contributions to colorectal cancer development

Allen, J., & Sears, C. L. (2019) · Genome Medicine · doi:10.1186/s13073-019-0621-2 · Cited by 205 · see citing works

The Multiple Roles of Interferon Regulatory Factor family in Health and Disease

Wang, L., Zhu, Y., Zhang, N., Xian, Y., Tang, Y., Ye, J., Reza, F., He, G., Wen, X., & Jiang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01980-4 · Cited by 178 · see citing works

Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease

Antonczyk, A., Krist, B., Sajek, M., Sekrecka, A., Piaszyk-Borychowska, A., Plens-Gałąska, M., Wesoły, J., & Bluyssen, H. A. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01176 · Cited by 156 · see citing works

MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer

Chen, L., Zhang, X., Wang, H., Liu, X.-M., Zhang, X., Zheng, B. J., Qian, G.-R., & Ma, Z. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.145 · Cited by 139 · see citing works

Activation of Vago by interferon regulatory factor (IRF) suggests an interferon system-like antiviral mechanism in shrimp

Li, C., Li, H., Chen, Y., Chen, Y., Wang, S., Weng, S., Xu, X., & He, J. (2015) · Scientific Reports · doi:10.1038/srep15078 · Cited by 131 · see citing works

IRF7: role and regulation in immunity and autoimmunity

Ma, W., Huang, G., Wang, Z., Wang, L., & Gao, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1236923 · Cited by 130 · see citing works

Quantification of Differential Transcription Factor Activity and Multiomics-Based Classification into Activators and Repressors: diffTF

Berest, I., Arnold, C., Reyes-Palomares, A., Palla, G., Rasmussen, K. D., Giles, H., Bruch, P.-M., Huber, W., Dietrich, S., Helin, K., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.106 · Cited by 119 · see citing works

Interferon-stimulated Gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma

Li, C., Wang, J., Zhang, H., Zhu, M., Chen, F., Hu, Y., Liu, H., & Zhu, H. (2014) · Oncotarget · doi:10.18632/oncotarget.2316 · Cited by 109 · see citing works

The Molecular Basis of Viral Inhibition of IRF- and STAT-Dependent Immune Responses

Chiang, H.-S., & Liu, H. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03086 · Cited by 108 · see citing works

Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer

Batista, I. A., & Helguero, L. A. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0017-6 · Cited by 106 · see citing works

Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses

Matveeva, O. V., & Chumakov, P. M. (2018) · Reviews in Medical Virology · doi:10.1002/rmv.2008 · Cited by 105 · see citing works

Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function

Rengachari, S., Groiss, S., Devos, J. M., Caron, E., Grandvaux, N., & Panne, D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718426115 · Cited by 91 · see citing works

Interferon Regulatory Factor 9 Structure and Regulation

Paul, A., Tang, T., & Ng, S. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01831 · Cited by 90 · see citing works

IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell

Shao, L., Hou, W., Scharping, N. E., Vendetti, F. P., Srivastava, R., Roy, C. N., Menk, A. V., Wang, Y., Chauvin, J.-M., Karukonda, P., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0711 · Cited by 90 · see citing works

Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance

Scott, M. L., Woodby, B. L., Ulicny, J., Raikhy, G., Orr, A. W., Songock, W. K., & Bodily, J. M. (2019) · Journal of Virology · doi:10.1128/jvi.01582-19 · Cited by 90 · see citing works

Interferon regulatory factor 1 inactivation in human cancer

Alsamman, K., & El-Masry, O. S. (2018) · Bioscience Reports · doi:10.1042/bsr20171672 · Cited by 84 · see citing works

Metabolic Programming of Macrophages: Implications in the Pathogenesis of Granulomatous Disease

Wilson, J. L., Mayr, H. K., & Weichhart, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02265 · Cited by 81 · see citing works

Revisiting IRF1-mediated antiviral innate immunity

Zhou, H., Tang, Y., & Zheng, C. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.01.004 · Cited by 82 · see citing works

Trial Watch

Aranda, F., Vacchelli, E., Obrist, F., Eggermont, A. M. M., Galon, J., Sautès‐Fridman, C., Cremer, I., ter Meulen, J. H., Zitvogel, L., Kroemer, G., et al. (2014) · OncoImmunology · doi:10.4161/onci.29179 · Cited by 81 · see citing works

Interferon regulatory factor 9 is critical for neointima formation following vascular injury

Zhang, S., Zhu, L., Chen, H., Zhang, R., Zhang, P., Jiang, D.-S., Gao, L., Tian, S., Wang, L., Zhang, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms6160 · Cited by 77 · see citing works

TF-DUBTACs Stabilize Tumor Suppressor Transcription Factors

Liu, J., Yu, X., Chen, H., Kaniskan, H. Ü., Xie, L., Chen, X., Jin, J., & Wei, W. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c04824 · Cited by 73 · see citing works

Transcriptional and chromatin regulation in interferon and innate antiviral gene expression

Au-Yeung, N., & Horvath, C. M. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.10.003 · Cited by 74 · see citing works

Cell-to-Cell Variation in Defective Virus Expression and Effects on Host Responses during Influenza Virus Infection

Wang, C., Forst, C. V., Chou, T.-W., Geber, A. B., Wang, M., Hamou, W., Smith, M. L., Sebra, R., Zhang, B., Zhou, B., et al. (2020) · mBio · doi:10.1128/mbio.02880-19 · Cited by 71 · see citing works

TLRs: Innate Immune Sentries against SARS-CoV-2 Infection

Mantovani, S., Oliviero, B., Varchetta, S., Renieri, A., & Mondelli, M. U. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098065 · Cited by 70 · see citing works

Rotavirus NSP1 Mediates Degradation of Interferon Regulatory Factors through Targeting of the Dimerization Domain

Arnold, M. M., Barro, M., & Patton, J. T. (2013) · Journal of Virology · doi:10.1128/jvi.01146-13 · Cited by 68 · see citing works

Bifurcation of signalling in human innate immune pathways to NF-kB and IRF family activation

Kusiak, A., & Brady, G. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115246 · Cited by 66 · see citing works

A Critical Role for Interferon Regulatory Factor 9 in Cerebral Ischemic Stroke

Chen, H., Guo, S., Li, Z.-Z., Lu, Y., Jiang, D.-S., Zhang, R., Lei, H. C., Gao, L., Zhang, X., Zhang, Y., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1545-14.2014 · Cited by 66 · see citing works

Characterization of the Mollusc RIG-I/MAVS Pathway Reveals an Archaic Antiviral Signalling Framework in Invertebrates

Huang, B., Zhang, L., Du, Y., Xu, F., Li, L., & Zhang, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-08566-x · Cited by 63 · see citing works

DC‐AL GAN: Pseudoprogression and true tumor progression of glioblastoma multiform image classification based on DCGAN and AlexNet

Li, M., Tang, H., Chan, M. D., Zhou, X., & Qian, X. (2019) · Medical Physics · doi:10.1002/mp.14003 · Cited by 62 · see citing works

Therapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based?

Thompson, C. D., Matta, B., & Barnes, B. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02622 · Cited by 56 · see citing works

lncRNA AFAP1-AS1 Promotes Migration and Invasion of Non-Small Cell Lung Cancer via Up-Regulating IRF7 and the RIG-I-Like Receptor Signaling Pathway

Tang, X., Zhang, D., Jia, L., Ji, W., & Zhao, Y.-S. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493967 · Cited by 56 · see citing works

CD74 as a regulator of transcription in normal B cells

David, K., Friedlander, G., Pellegrino, B., Radomir, L., Lewinsky, H., Leng, L., Bucala, R., Becker-Herman, S., & Shachar, I. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111572 · Cited by 55 · see citing works

ExplaiNN: interpretable and transparent neural networks for genomics

Novakovsky, G., Fornés, O., Saraswat, M., Mostafavi, S., & Wasserman, W. W. (2023) · Genome biology · doi:10.1186/s13059-023-02985-y · Cited by 55 · see citing works

Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

Spiliopoulou, P., Spear, S., Mirza, H., Garner, I., McGarry, L., Grundland-Freile, F., Cheng, Z., Ennis, D. P., Iyer, N., McNamara, S., et al. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0743 · Cited by 51 · see citing works

Origins and diversification of animal innate immune responses against viral infections

Iwama, R. E., & Moran, Y. (2023) · Nature Ecology & Evolution · doi:10.1038/s41559-022-01951-4 · Cited by 51 · see citing works

LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation

Profumo, V., Forte, B., Percio, S., Rotundo, F., Doldi, V., Ferrari, E., Fenderico, N., Dugo, M., Romagnoli, D., Benelli, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08153-2 · Cited by 51 · see citing works

Distinctive Roles for Type I and Type II Interferons and Interferon Regulatory Factors in the Host Cell Defense against Varicella-Zoster Virus

Sen, N., Sung, P., Panda, A., & Arvin, A. M. (2018) · Journal of Virology · doi:10.1128/jvi.01151-18 · Cited by 47 · see citing works

Circadian oscillations of cytosine modification in humans contribute to epigenetic variability, aging, and complex disease

Oh, G., Koncevičius, K., Ebrahimi, S. B., Carlucci, M., Groot, D. E., Nair, A., Zhang, A., Kriščiūnas, A., Oh, E. S., Labrie, V., et al. (2019) · Genome biology · doi:10.1186/s13059-018-1608-9 · Cited by 46 · see citing works

Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma

Hua, X., Chen, J., Yang, S., & Liang, C. Y. (2020) · Aging · doi:10.18632/aging.102746 · Cited by 45 · see citing works

The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases

Zhang, X., Jiang, D., & Li, H. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12881 · Cited by 44 · see citing works

The Structural Basis of IRF-3 Activation upon Phosphorylation

Jing, T., Zhao, B., Xu, P., Gao, X., Chi, L., Han, H., Sankaran, B., & Li, P. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000026 · Cited by 42 · see citing works

Transcriptional control of metabolism by interferon regulatory factors

Ahmad, Z., Kahloan, W., & Rosen, E. D. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00990-0 · Cited by 42 · see citing works

miR‑18a‑5p promotes cell invasion and migration of osteosarcoma by directly targeting IRF2

Lu, C., Peng, K., Guo, H., Ren, X., Hu, S., Cai, Y., Han, Y., Ma, L., & Xu, P. (2018) · Oncology Letters · doi:10.3892/ol.2018.9032 · Cited by 42 · see citing works

Identification of cGAS as an innate immune sensor of extracellular bacterium Pseudomonas aeruginosa

Zhou, C., Wang, B., Wu, Q., Lin, P., Qin, S., Pu, Q., Yu, X.-J., & Wu, M. (2020) · iScience · doi:10.1016/j.isci.2020.101928 · Cited by 41 · see citing works

Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review

Kaur, H., Sarma, P., Bhattacharyya, A., Sharma, S., Chhimpa, N., Prajapat, M., Prakash, A., Kumar, S., Singh, A. K., Singh, R. S., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174233 · Cited by 40 · see citing works

A conserved interferon regulation factor 1 (IRF-1) from Pacific oyster Crassostrea gigas functioned as an activator of IFN pathway

Lu, M., Yang, C., Li, M., Yi, Q., Lu, G., Wu, Y., Qu, C., Wang, L., & Song, L. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.02.024 · Cited by 40 · see citing works

SUMO modification of TBK1 at the adaptor-binding C-terminal coiled-coil domain contributes to its antiviral activity

Saul, V. V., Niedenthal, R. K., Pich, A., Weber, F., & Schmitz, M. L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.10.008 · Cited by 39 · see citing works

Characterization of Innate Responses Induced by PLGA Encapsulated- and Soluble TLR Ligands In Vitro and In Vivo in Chickens

Alkie, T. N., Taha-Abdelaziz, K., Barjesteh, N., Bavananthasivam, J., Hodgins, D. C., & Sharif, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169154 · Cited by 39 · see citing works

Biomarkers and Associated Immune Mechanisms for Early Detection and Therapeutic Management of Sepsis

Trzeciak, A. J., Pietropaoli, A. P., & Kim, M. (2020) · Immune Network · doi:10.4110/in.2020.20.e23 · Cited by 51 · see citing works

The Roles of Interferon Regulatory Factors 1 and 2 in the Progression of Human Pancreatic Cancer

Sakai, T., Mashima, H., Yamada, Y., Goto, T., Sato, W., Dohmen, T., Kamada, K., Yoshioka, M., Uchinami, H., Yamamoto, Y., et al. (2014) · Pancreas · doi:10.1097/mpa.0000000000000116 · Cited by 37 · see citing works

Porcine bocavirus NP1 negatively regulates interferon signaling pathway by targeting the DNA-binding domain of IRF9

Zhang, R., Fang, L., Wang, D., Cai, K., Zhang, H., Xie, L., Li, Y., Chen, H., & Xiao, S. (2015) · Virology · doi:10.1016/j.virol.2015.08.005 · Cited by 37 · see citing works

Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study

Qian, X., Tan, H., Zhang, J., Liu, K., Yang, T., Wang, M., Debinskie, W., Zhao, W., Chan, M. D., & Zhou, X. (2016) · Oncotarget · doi:10.18632/oncotarget.10553 · Cited by 36 · see citing works

IRF4 as an Oncogenic Master Transcription Factor

Wong, R. W. J., Ong, J. Z. L., Theardy, M. S., & Sanda, T. (2022) · Cancers · doi:10.3390/cancers14174314 · Cited by 38 · see citing works

Proteomic profiling of iPSC and tissue-derived MSC secretomes reveal a global signature of inflammatory licensing

Hodgson‐Garms, M., Moore, M., Martino, M. M., Kelly, K., & Frith, J. E. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-024-00382-y · Cited by 39 · see citing works

Deubiquitinase-Targeting Chimeras (DUBTACs) as a Potential Paradigm-Shifting Drug Discovery Approach

Ma, Z., Zhou, M., Chen, H., Shen, Q., & Zhou, J. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02975 · Cited by 37 · see citing works

Rotavirus Strategies Against the Innate Antiviral System

López, S., Sánchez-Tacuba, L., Moreno-Contreras, J., & Arias, C. F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042152 · Cited by 35 · see citing works

RNA regulatory mechanisms that control antiviral innate immunity

Gokhale, N. S., Smith, J. R., Gelder, R. D. V., & Savan, R. (2021) · Immunological Reviews · doi:10.1111/imr.13019 · Cited by 34 · see citing works

Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/β-catenin signaling in colorectal cancer cells

Ohsugi, T., Yamaguchi, K., Zhu, C., Ikenoue, T., Takane, K., Shinozaki, M., Tsurita, G., Yano, H., & Furukawa, Y. (2019) · Oncogene · doi:10.1038/s41388-019-0856-9 · Cited by 34 · see citing works

Immune cells surveil aberrantly sialylated O-glycans on megakaryocytes to regulate platelet count

Lee‐Sundlov, M. M., Burns, R. T., Kim, T. O., Grozovsky, R., Giannini, S., Rivadeneyra, L., Zheng, Y., Glabere, S. H., Kahr, W. H. A., Abdi, R., et al. (2021) · Blood · doi:10.1182/blood.2020008238 · Cited by 33 · see citing works

Alternative Splicing in Cancer and Immune Cells

Bernard, A., Boidot, R., & Végran, F. (2022) · Cancers · doi:10.3390/cancers14071726 · Cited by 33 · see citing works

Gene networks and transcriptional regulators associated with liver cancer development and progression

Meier, T., Timm, M., Montani, M., & Wilkens, L. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00883-5 · Cited by 31 · see citing works

Interferon Stimulated Gene - ISG15 is a Potential Diagnostic Biomarker in Oral Squamous Cell Carcinomas

Laljee, R. P., Muddaiah, S., Salagundi, B. S., Cariappa, P. M., Indra, A. S., Sanjay, V., & Ramanathan, A. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.2.1147 · Cited by 31 · see citing works

Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases

Zhang, Y., & Li, H. (2017) · Physiology · doi:10.1152/physiol.00038.2016 · Cited by 31 · see citing works

MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells

Yan, Y., Liang, Z., Du, Q., Yang, M., & Geller, D. A. (2016) · Oncology Reports · doi:10.3892/or.2016.4864 · Cited by 30 · see citing works

Interferon Gamma Inhibits Varicella-Zoster Virus Replication in a Cell Line-Dependent Manner

Shakya, A. K., O’Callaghan, D. J., & Kim, S. K. (2019) · Journal of Virology · doi:10.1128/jvi.00257-19 · Cited by 29 · see citing works

Molecular characterization of the interferon regulatory factor (IRF) family and functional analysis of IRF11 in the large yellow croaker (Larimichthys crocea)

Guan, Y., Chen, X., Luo, T., Ao, J., Ai, C., & Chen, X. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.10.001 · Cited by 30 · see citing works

Characterization of Amphioxus IFN Regulatory Factor Family Reveals an Archaic Signaling Framework for Innate Immune Response

Yuan, S., Zheng, T., Li, P., Yang, R., Ruan, J., Huang, S., Wu, Z., & Xu, A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501927 · Cited by 29 · see citing works

Effect of novel leukemia mutations (K75E & E222K) on interferon regulatory factor 1 and its interaction with DNA: insights from molecular dynamics simulations and docking studies

Kamaraj, B., Al‐Subaie, A. M., Ahmad, F., Surapaneni, K. M., & Alsamman, K. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1784790 · Cited by 29 · see citing works

Immune microenvironment of cervical cancer and the role of IL-2 in tumor promotion

Trujillo-Cirilo, L., Weiss‐Steider, B., Vargas-Ángeles, C. A., Corona-Ortega, M. T., & Rangel-Corona, R. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156334 · Cited by 29 · see citing works

Comprehensive analysis of expression profile and prognostic significance of interferon regulatory factors in pancreatic cancer

Zhang, K., Xu, P., Li, Y., Dong, S., Gao, H., Chen, L., Chen, H., & Chen, Z. (2022) · BMC Genomic Data · doi:10.1186/s12863-021-01019-5 · Cited by 28 · see citing works

IRF2 contributes to myocardial infarction via regulation of GSDMD induced pyroptosis

Li, Y., Wang, Y., Guo, H., Wu, Q., & Hu, Y. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12556 · Cited by 28 · see citing works

Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion

Wang, H., Zhang, D., Cui, X., Dai, Y., Wang, C., Feng, W., Lv, X., Li, Y., Wang, L., Ru, Y., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02233-w · Cited by 28 · see citing works

IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer

Rho, S. B., Lee, S., Byun, H., Kim, B.-R., & Lee, C. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207622 · Cited by 27 · see citing works

Ubiquitination network in the type I IFN‐induced antiviral signaling pathway

Zhao, Q., Zhang, R., Qiao, C., Miao, Y., Yuan, Y., & Zheng, H. (2023) · European Journal of Immunology · doi:10.1002/eji.202350384 · Cited by 27 · see citing works

RelA-Induced Interferon Response Negatively Regulates Proliferation

Kochupurakkal, B. S., Wang, Z. C., Hua, T., Culhane, A. C., Rodig, S. J., Molek, K. R., Lazaro, J., Richardson, A. L., Biswas, D. K., & Iglehart, J. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140243 · Cited by 27 · see citing works

The EF-Hand Protein CALML6 Suppresses Antiviral Innate Immunity by Impairing IRF3 Dimerization

Wang, Z., Sheng, C., Yao, C., Chen, H., Wang, D., & Chen, S. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.030 · Cited by 26 · see citing works

Circular RNA hsa_circ_0000658 inhibits osteosarcoma cell proliferation and migration via the miR‐1227/IRF2axis

Jiang, X., & Chen, D. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16105 · Cited by 26 · see citing works

IRF1 and IRF2 act as positive regulators in antiviral response of large yellow croaker (Larimichthys crocea) by induction of distinct subgroups of type I IFNs

Chen, X., Guan, Y., Li, K., Luo, T., Mu, Y., & Chen, X. (2021) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2021.103996 · Cited by 25 · see citing works

Comparative Analysis of Six IRF Family Members in Alveolar Epithelial Cell-Intrinsic Antiviral Responses

Wüst, S., Schad, P. S., Burkart, S. S., & Binder, M. (2021) · Cells · doi:10.3390/cells10102600 · Cited by 23 · see citing works

Evolution of the IRF Family in Salmonids

Clark, T. C., Boudinot, P., & Collet, B. (2021) · Genes · doi:10.3390/genes12020238 · Cited by 23 · see citing works

ISG15 as a novel prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma.

Qiu, X., Yuan, H., Yang, D., Xia, M., Zhu, H., Li, Q., Xie, H., Wu, Q., Liu, C., & Zuo, C. (2015) · PubMed Central · Cited by 23 · see citing works

Innate Immune Responses to Herpesvirus Infection

O’Connor, C. M., & Sen, G. C. (2021) · Cells · doi:10.3390/cells10082122 · Cited by 22 · see citing works

Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME

Kumar, V., Bauer, C., & Stewart, J. H. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00942-2 · Cited by 23 · see citing works

A dual role of Irf1 in maintaining epithelial identity but also enabling EMT and metastasis formation of breast cancer cells

Meyer‐Schaller, N., Tiede, S., Ivánek, R., Diepenbruck, M., & Christofori, G. (2020) · Oncogene · doi:10.1038/s41388-020-1326-0 · Cited by 21 · see citing works

Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican

Brunn, D., Turkowski, K., Günther, S., Weigert, A., Muley, T., Kriegsmann, M., Winter, H., Dammann, R., Stathopoulos, G. T., Thomas, M., et al. (2021) · Cancers · doi:10.3390/cancers13020208 · Cited by 21 · see citing works

MiR-139 Induces an Interferon-β Response in Prostate Cancer Cells by Binding to RIG-1

Nam, R. K., Benatar, T., Amemiya, Y., & Seth, A. K. (2021) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20252 · Cited by 21 · see citing works

Full characterization and transcript expression profiling of the interferon regulatory factor (IRF) gene family in Atlantic cod (Gadus morhua)

Inkpen, S. M., Solbakken, M. H., Jentoft, S., Eslamloo, K., & Rise, M. L. (2019) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2019.03.015 · Cited by 20 · see citing works

The innate immune signaling in cancer and cardiometabolic diseases: Friends or foes?

Wang, W., Zhang, Y., Yang, L., & Li, H. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.06.004 · Cited by 20 · see citing works

Swine IRF3/IRF7 attenuates inflammatory responses through TLR4 signaling pathway

Chen, P.-G., Guan, Y.-J., Zha, G., Jiao, X.-Q., He-shui, Z., Zhang, C., Wang, Y., & Li, H. (2017) · Oncotarget · doi:10.18632/oncotarget.18740 · Cited by 20 · see citing works

MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2

Li, X., Zhou, C., Zhang, C., Xie, X., Zhou, Z., Zhou, M., Chen, L., & Ding, Z. (2019) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2019.05.004 · Cited by 20 · see citing works

Ubiquitination modification: critical regulation of IRF family stability and activity

Liu, B.-Q., Jin, J., & Li, Y.-Y. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1796-0 · Cited by 17 · see citing works

Upregulation of Interferon Regulatory Factor 6 Promotes Neuronal Apoptosis After Traumatic Brain Injury in Adult Rats

Lin, Y., Xu, D., Li, X., Liu, C., Liu, X., Huang, S., Huang, Y., & Liu, X. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0217-3 · Cited by 20 · see citing works

Interferon regulatory factor 5: a potential target for therapeutic intervention in inflammatory diseases

Yu, X., Rehman, A. U., Dang, L., Zhang, X., Liu, J., Xiong, X., Chen, G., & Jian, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1535823 · Cited by 19 · see citing works

Lack of IRF6 Disrupts Human Epithelial Homeostasis by Altering Colony Morphology, Migration Pattern, and Differentiation Potential of Keratinocytes

Girousi, E., Muerner, L., Parisi, L., Rihs, S., von Gunten, S., Katsaros, C., & Degen, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.718066 · Cited by 19 · see citing works

Interferon regulatory factor family of transcription factors and regulation of oncogenesis

Takaoka, A., Tamura, T., & Taniguchi, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00720.x · Cited by 150 · see citing works

Regulation of immunity and oncogenesis by the IRF transcription factor family

Savitsky, D., Tamura, T., Yanai, H., & Taniguchi, T. (2010) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-009-0804-6 · Cited by 298 · see citing works

The interferon regulatory factors and oncogenesis

Tanaka, N., & Taniguchi, T. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0310 · Cited by 85 · see citing works

The IRF Family Transcription Factors in Immunity and Oncogenesis

Tamura, T., Yanai, H., Savitsky, D., & Taniguchi, T. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090400 · Cited by 1,259 · see citing works

Genetic and Epigenetic Regulation of Interferon Regulatory Factor Expression: Implications in Human Malignancies

Fragale, A. (2013) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000205 · Cited by 6 · see citing works